Steven Cohen Autolus Therapeutics PLC Transaction History
Point72 Asset Management, L.P.
- $39.3 Billion
- Q1 2024
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Autolus Therapeutics PLC stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 37,300 shares of AUTL stock, worth $128,685. This represents 0.0% of its overall portfolio holdings.
Number of Shares
37,300Holding current value
$128,685% of portfolio
0.0%Shares
5 transactions
Others Institutions Holding AUTL
# of Institutions
123Shares Held
168MCall Options Held
411KPut Options Held
67.6K-
Syncona Portfolio LTD Guernsey, Channel Islands, X021.3MShares$73.6 Million90.76% of portfolio
-
Blackstone Inc New York, NY20.5MShares$70.7 Million0.54% of portfolio
-
Deep Track Capital, LP Greenwich, CT15.3MShares$52.7 Million3.22% of portfolio
-
Avoro Capital Advisors LLC New York, NY12.3MShares$42.6 Million0.95% of portfolio
-
Wellington Management Group LLP Boston, MA10.8MShares$37.1 Million0.01% of portfolio
About Autolus Therapeutics plc
- Ticker AUTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 90,909,800
- Market Cap $314M
- Description
- Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...